HALLADAY BENJAMIN (Chief Financial Officer) reported 1 transaction at ESPERION THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/13/2026ACC: 0001628280-26-048000
Officer· Chief Financial Officer
Since Nov 2022
-1.34M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
1.34M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−705.41K
Price / share
—
Trade value
—
% of position
New position
7/13/2026
705.41K→0.00
Total
Net shares
−705.41K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/13/2026 | D · Disposition | −705.41K | — | — | New position | 705.41K | 0.00 |
| Total | −705.41K | $0.00 | ||||||
Derivative Transactions3
Stock Option (right to buy)
Direct
Converts to
Common Stock
200K shares
Shares
−200K
Strike price
2.05
Held after
0.00
Exercisable
—
7/13/2026
Stock Option (right to buy)
Direct
Converts to
Common Stock
213K shares
Shares
−213K
Strike price
1.50
Held after
0.00
Exercisable
—
7/13/2026
Stock Option (right to buy)
Direct
Converts to
Common Stock
221.27K shares
Shares
−221.27K
Strike price
2.44
Held after
0.00
Exercisable
—
7/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock200K shares | 7/13/2026 | D · Disposition | −200K | 2.05 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock213K shares | 7/13/2026 | D · Disposition | −213K | 1.50 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock221.27K shares | 7/13/2026 | D · Disposition | −221.27K | 2.44 | — | 0.00 |